Riskpilot← Back to searchSign inGet full accessENTPRO AB
ABActiveOrg 5566148184StockholmResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20013 employees
Revenue 2024
SEK 14,4M
+19% vs 2023
EBITDA margin
-13.7%
+20% vs 2023
Equity ratio
2.1%
Financial strength
Net profit 2024
SEK -2M
+18% vs 2023
| Revenue | SEK 14,4M | +19% |
| EBITDA | SEK -2M | +20% |
| Net profit | SEK -2M | +18% |
| Total assets | SEK 7,8M | +33% |
| Equity | SEK 164K | +25% |
| Employees | 3 | — |
Legal name
ENTPRO AB
Org number
5566148184
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
30 augusti 2001
Share capital
SEK 123 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva forskning, produktutveckling, tillverkning, marknadsföring och försäljning av medicinsk tekniska och hygieni- ska produkter. Medicinkonsultuppdrag såsom forskning, utbildning samt även bemanningsuppdrag inom sjukvården (läkare och sjukskö- terskor) handel med värdepapper samt därmed förenlig verksamhet.
Address
Stockholm
Phone
+4687202990
Email
info@entpro.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 4 100 | 5 125 | 5 920 | 5 278 | 5 804 | 9 453 | 12 097 | 14 406 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 104 | 594 | 542 | 1 484 | −118 | 123 | 282 | −636 | −2 475 | −1 969 |
| Depreciation & amort. | −55 | −38 | −9 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 49 | 556 | 533 | 1 484 | −118 | 123 | 282 | −636 | −2 475 | −1 969 |
| Net financials | −3 | −3 | −6 | −17 | −58 | −147 | −44 | 4 | −14 | 2 |
| Profit before tax | 47 | 414 | 406 | 1 108 | −102 | 40 | 184 | −49 | −2 399 | −1 967 |
| Tax | −13 | −93 | −94 | −245 | −0 | −0 | −34 | −0 | −2 | −0 |
| Net profit | 34 | 321 | 312 | 863 | −102 | 40 | 150 | −49 | −2 401 | −1 967 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 802 | 1 994 | 2 092 | 3 586 | 3 566 | 3 479 | 4 901 | 9 070 | 5 863 | 7 826 |
| Equity | 1 173 | 1 043 | 979 | 1 843 | 1 741 | 1 781 | 1 931 | 1 882 | 131 | 164 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 491 | 673 | 714 | 985 | 1 140 | 1 079 | 2 297 | 7 098 | 5 732 | 7 662 |
| Total debt | 491 | 673 | 714 | 985 | 1 140 | 1 079 | 2 297 | 7 098 | 5 732 | 7 662 |
EBITDA margin
-13.7%
This company
15.8%
Market median
-187% vs market
20152024
Equity ratio
2.1%
This company
38.2%
Market median
-95% vs market
20152024
Return on equity
-1199.4%
This company
18.4%
Market median
-6618% vs market
20152024
Net profit margin
-13.7%
This company
8.1%
Market median
-269% vs market
20152024
Asset turnover
1.84×
This company
1.12×
Market median
+64% vs market
20152024
Debt / equity
46.72×
This company
0.62×
Market median
-7435% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CL Authorized Recipient of Service | Authorized Recipient of Service | 2021 | — | — |
FM | Audit | 2022 | — | — |
PM Chief Auditor | Chief Auditor | 2025 | — | — |
PM Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
CF Audit | Audit | 2020 | — | — |
BG Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
HR Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ENTPRO AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl-Johan Lye | Authorized Recipient of Service | 0 companies |
| Frida Marianne Sylvén | Audit | 0 companies |
| Peter Magnus Kangas | Chief Auditor | 0 companies |
| Peter Michael Georg Åhnblad | Chief Executive Officer | 0 companies |
| Carl Fredrik Niring | Audit | 0 companies |
| Björn Gustav Freyne | Chief Executive Officer | 0 companies |
| Hans Rudolf Joachim Kahlau | Chief Executive Officer | 0 companies |
| Ketan Chandrakant Mehta | Chairman | 0 companies |
| Nina Mehta | Board of Directors | 0 companies |
| Kamal Mistry | Board of Directors | 0 companies |